iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Polymyalgia Rheumatica (PMR)

Polymyalgia Rheumatica (PMR)

Diagnosis and management of PMR.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Rheumatology

Clinical Guidelines

British Society for Rheumatology guideline on management of polymyalgia rheumatica
National
CKS: Polymyalgia rheumatica
National
CKS: Polymyalgia Rheumatica
National
Guidelines for the Management of Polymyalgia Rheumatica (PMR)
National
NICE guideline [NG180]
National
2015 Recommendations for the management of polymyalgia rheumatica (EULAR/ACR collaborative initiative)
Local
BSR and BHPR guidelines for the management of polymyalgia rheumatica
Local
Norwegian society of rheumatology recommendations on diagnosis and management of polymyalgia rheumatica
Local
The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica
Local

Recent iatroX Q&As

  • How should I approach the initial management of a patient diagnosed with Polymyalgia Rheumatica?Updated: 8/16/2025
  • What investigations are recommended to rule out other conditions when suspecting Polymyalgia Rheumatica?Updated: 8/16/2025
  • When should I consider referring a patient with Polymyalgia Rheumatica to a rheumatologist?Updated: 8/16/2025
  • What are the potential side effects of corticosteroid treatment in patients with Polymyalgia Rheumatica, and how can they be managed?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play